ODI Pharma
1.60 SEK
+8.11 %
Less than 1K followers
ODI
Spotlight Stock Market
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Investor consensus
+8.11 %
+21.21 %
+3.23 %
-20.79 %
-27.93 %
-44.06 %
-59.52 %
-69.75 %
-85.75 %
ODI Pharma is a producer and supplier of medical cannabis products. The business is run through subsidiaries and partners where sales are made through wholesale distributors and pharmacies. The products are used for the treatment of, for example, multiple sclerosis, chronic pain and chemotherapy. Operations are found within the European market, with the headquarters in Stockholm.
Read moreMarket cap
29.33M SEK
Turnover
16.19K SEK
Revenue
3.11M
EBIT %
-168.49 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
5.12
2025
General meeting '25
26.2
2026
Interim report Q2'26
28.5
2026
Interim report Q3'26
All
Press releases
ShowingAll content types
ODI Pharma demonstrates clear operational progress and improved commercial outlook
ODI Pharma AB publishes the annual report for the fiscal year 2024/2025
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools